Dashboard
Manage Tickers

CNCCENTENE CORP

NYSE centene.com


$ 71.58 $ 2.63 (3.81 %)    

Friday, 31-May-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 454.82 $ -0.01 (-0 %)
DIA $ 398.57 $ 6.05 (1.59 %)
SPY $ 530.36 $ 4.59 (0.88 %)
TLT $ 91.26 $ 0.69 (0.77 %)
GLD $ 225.37 $ -1.27 (-0.59 %)
$ 71.59
$ 70.33
$ 0.00 x 0
$ 0.00 x 0
$ 70.06 - $ 71.68
$ 60.83 - $ 81.42
6,991,246
na
38.52B
$ 0.94
$ 14.08
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-25-2024 03-31-2024 10-Q
2 02-20-2024 12-31-2023 10-K
3 10-23-2023 09-30-2023 10-Q
4 07-27-2023 06-30-2023 10-Q
5 04-25-2023 03-31-2023 10-Q
6 02-21-2023 12-31-2022 10-K
7 10-25-2022 09-30-2022 10-Q
8 07-26-2022 06-30-2022 10-Q
9 04-26-2022 03-31-2022 10-Q
10 02-22-2022 12-31-2021 10-K
11 10-26-2021 09-30-2021 10-Q
12 07-26-2021 06-30-2021 10-Q
13 04-27-2021 03-31-2021 10-Q
14 02-22-2021 12-31-2020 10-K
15 10-27-2020 09-30-2020 10-Q
16 07-28-2020 06-30-2020 10-Q
17 04-28-2020 03-31-2020 10-Q
18 02-18-2020 12-31-2019 10-K
19 10-22-2019 09-30-2019 10-Q
20 07-23-2019 06-30-2019 10-Q
21 04-23-2019 03-31-2019 10-Q
22 02-19-2019 12-31-2018 10-K
23 10-23-2018 09-30-2018 10-Q
24 07-24-2018 06-30-2018 10-Q
25 04-24-2018 03-31-2018 10-Q
26 02-20-2018 12-31-2017 10-K
27 10-24-2017 09-30-2017 10-Q
28 07-25-2017 06-30-2017 10-Q
29 04-25-2017 03-31-2017 10-Q
30 02-21-2017 12-31-2016 10-K
31 10-25-2016 09-30-2016 10-Q
32 07-26-2016 06-30-2016 10-Q
33 04-26-2016 03-31-2016 10-Q
34 02-22-2016 12-31-2015 10-K
35 10-27-2015 09-30-2015 10-Q
36 07-28-2015 06-30-2015 10-Q
37 04-28-2015 03-31-2015 10-Q
38 02-23-2015 12-31-2014 10-K
39 10-28-2014 09-30-2014 10-Q
40 07-22-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

stephens--co-reiterates-equal-weight-on-centene-maintains-83-price-target
Stephens & Co. Reiterates Equal-Weight on ...
05/30/2024 15:53:41

Stephens & Co. analyst Scott Fidel reiterates Centene (NYSE:CNC) with a Equal-Weight and maintains $83 price target.

what-11-analyst-ratings-have-to-say-about-centene
What 11 Analyst Ratings Have To Say About ...
05/30/2024 14:00:39

baird-initiates-coverage-on-centene-with-neutral-rating-announces-price-target-of-83
Baird Initiates Coverage On Centene with N...
05/30/2024 09:50:40

Baird analyst Michael Ha initiates coverage on Centene (NYSE:CNC) with a Neutral rating and announces Price Target of $83.

centene-expects-to-reaffirm-fy24-adjusted-eps-guidance-of-greater-than-680-est-685
Centene Expects To Reaffirm FY24 Adjusted ...
05/29/2024 20:58:39

The Company expects to reaffirm the 2024 full year adjusted EPS guidance of greater than $6.80 and full year consolidated healt...

why-unitedhealth-stock-is-sliding-wednesday
Why UnitedHealth Stock Is Sliding Wednesday
05/29/2024 19:57:31

UnitedHealth Group Inc. (NYSE: UNH) saw its shares decline significantly following remarks made by CEO Andrew Witty at the Bern...

heres-how-much-you-would-have-made-owning-centene-stock-in-the-last-15-years
Here's How Much You Would Have Made Owning...
05/29/2024 16:00:34

heres-how-much-you-would-have-made-owning-centene-stock-in-the-last-10-years
Here's How Much You Would Have Made Owning...
05/14/2024 19:30:24

heres-how-much-1000-invested-in-centene-20-years-ago-would-be-worth-today
Here's How Much $1000 Invested In Centene ...
05/06/2024 14:00:41

4-stocks-that-are-looking-like-a-great-value-right-now
4 Stocks That Are Looking Like A Great Val...
05/03/2024 13:28:43

These four companies appear to be a good deal based on future earnings expectations and trading at a low price/earnings (P/E) r...

10-analysts-assess-centene-what-you-need-to-know
10 Analysts Assess Centene: What You Need ...
05/02/2024 19:01:11

barclays-maintains-overweight-on-centene-raises-price-target-to-104
Barclays Maintains Overweight on Centene, ...
05/02/2024 14:42:38

Barclays analyst Andrew Mok maintains Centene (NYSE:CNC) with a Overweight and raises the price target from $101 to $104.

wellcare-the-medicare-business-of-centene-corp-and-wellvana-announce-partnership-to-expand-patient-centered-primary-care-for-benefit-of-medicare-advantage-members-in-georgia-tennessee-and-texas
Wellcare, The Medicare Business Of Centene...
05/02/2024 13:16:09

Wellcare, the Medicare business of Centene Corporation (NYSE:CNC), and Wellvana, a value-based care physician enablement compan...

deutsche-bank-maintains-hold-on-centene-raises-price-target-to-82
Deutsche Bank Maintains Hold on Centene, R...
04/30/2024 16:48:47

Deutsche Bank analyst George Hill maintains Centene (NYSE:CNC) with a Hold and raises the price target from $81 to $82.

oppenheimer-maintains-outperform-on-centene-maintains-110-price-target
Oppenheimer Maintains Outperform on Centen...
04/29/2024 17:06:27

Oppenheimer analyst Michael Wiederhorn maintains Centene (NYSE:CNC) with a Outperform and maintains $110 price target.

centenes-first-quarter-surge-sales-soar-to-4041b-exceeding-expectations-whats-next-for-the-healthcare-company
Centene's First-Quarter Surge: Sales Soar ...
04/26/2024 14:20:25

Centene outperforms expectations with $40.41 billion in Q1 sales, driven by robust growth in premium revenues and steady member...

centene-shares-are-trading-higher-after-the-company-reported-better-than-expected-q1-2024-adjusted-eps-and-sales-additionally-the-company-raised-upbeat-its-guidance-for-2024
Centene shares are trading higher after th...
04/26/2024 12:18:42

centene-expects-2024-revenue-guidance-of-1475b-1505b-versus-consensus-of-14614b-including-premium-and-service-revenues-of-1355b-1385b-versus-prior-guidance-of-1345b-1375b
Centene Expects 2024 Revenue Guidance Of $...
04/26/2024 10:11:47

centene-revises-its-2024-adjusted-eps-guidance-floor-of-greater-than-680-versus-prior-guidance-of-greater-than-670-versus-consensus-of-678
Centene Revises Its 2024 Adjusted EPS Guid...
04/26/2024 10:08:57

centene-reports-q1-health-benefits-ratio-of-871-with-membership-of-28422800
Centene Reports Q1 Health Benefits Ratio O...
04/26/2024 10:05:08

centene-q1-2024-adj-eps-226-beats-208-estimate-sales-40407b-beat-36536b-estimate
Centene Q1 2024 Adj EPS $2.26 Beats $2.08 ...
04/26/2024 10:02:45

Centene (NYSE:CNC) reported quarterly earnings of $2.26 per share which beat the analyst consensus estimate of $2.08 by 8.65 pe...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION